Clinical Trial Update: ATLANTIS Trial: Phospholipid Omega-3 Versus Conventional Omega-3 [NA]

View source ↗

Summary

The ATLANTIS trial compares phospholipid omega-3 to conventional omega-3 in adults with mixed dyslipidemia. The study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mixed Dyslipidemia

Drugs mentioned

• Conventional omega-3 (Omega-3 fatty acids (conventional formulation))
• Phospholipid omega-3 (Omega-3 fatty acids in phospholipid form)

Snippet

Sponsor: Fundación del Caribe para la Investigación Biomédica | Conditions: Mixed Dyslipidemia | NA | Status: NOT_YET_RECRUITING